Allstar Health Brands, Inc. (OTCPK: ALST)
Health Care · Pharmaceuticals · CA
$0.00
+33.33% today · -33.3% 1Y
Allstar Health Brands, Inc. (OTCPK: ALST) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $140.05K and employs 1 people.
Over the last twelve months the share price has lost 33.3%, trading between 0.00 and 0.00.
Tweenvest scores Allstar Health Brands, Inc. across four factors: quality 5/100, value 55/100. Its strongest factor is value.
ALST price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $140.05K
- Revenue (TTM)
- $45.76K
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- -0.25
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 350.13M
- Employees
- 1
- Next earnings
- —
About Allstar Health Brands, Inc.
Allstar Health Brands, Inc., a specialty health care products company, focuses on enhancing health and quality of life by offering select medicines, natural nutritional supplements, and over the counter remedies in the Americas. The company holds the Tapout license to sell globally branded nutraceutical products, including pain relief sprays and wipes. It has partnership with World Wide Entertainment (WWE) to market and sell their line of Tapout nutraceutical products. Allstar Health Brands, Inc. was formerly known as Axxess Pharma, Inc. and changed its name to Allstar Health Brands, Inc. in June 2017. The company was founded in 1997 and is headquartered in Toronto, Canada.
- ISIN
- US01989F2083
- Founded
- 1997
- Listed since
- Dec 1, 2009
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,256.11 | +0.06% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.93 | +0.63% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.78 | +0.15% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.25% |
Figures last refreshed Aug 18, 2026.